miR-18a increases insulin sensitivity by inhibiting PTEN.

Area of Science:

• Molecular Biology
• Genetics
• Endocrinology

Background:

• The miR-17-92 cluster, including miR-18a, plays a role in various diseases by regulating target genes.
• Dysregulation of microRNAs is implicated in metabolic disorders like type 2 diabetes mellitus.
• Understanding the specific role of miR-18a in insulin regulation is crucial for therapeutic development.

Purpose of the Study:

• To investigate the effect of miR-18a on insulin sensitivity and glucose metabolism.
• To explore the molecular mechanism by which miR-18a influences insulin signaling pathways.
• To assess the potential of miR-18a as a therapeutic target for type 2 diabetes.

Main Methods:

• Quantitative real-time PCR to measure serum miR-18a levels in patients with type 2 diabetes and healthy controls.
• Generation of transgenic mice with global miR-18a overexpression to assess in vivo effects on glucose tolerance and insulin sensitivity.
• Western blotting analysis in 3T3-L1 and C2C12 cell lines to evaluate the impact of miR-18a on PTEN expression and AKT phosphorylation.

Main Results:

• Serum miR-18a levels were significantly lower in type 2 diabetes mellitus patients compared to healthy individuals.
• Overexpression of miR-18a in transgenic mice led to improved glucose tolerance and enhanced insulin sensitivity.
• miR-18a overexpression suppressed PTEN expression and increased insulin-stimulated AKT phosphorylation in skeletal muscle, adipose tissue, and cell lines.

Conclusions:

• miR-18a plays a protective role in regulating insulin sensitivity and glucose homeostasis.
• The mechanism involves the downregulation of phosphatase and tensin homolog deleted on chromosome ten (PTEN).
• miR-18a represents a promising therapeutic target for managing type 2 diabetes mellitus.